Comparative Study of the Myocardium of Patients from Four COVID-19 Waves

Л. Б. Митрофанова, Igor Makarov, Andrey Gorshkov, A. L. Runov, Maxim Vonsky, Maria Pisareva, Andrey B. Komissarov, T. А. Makarova, Qingli Li, Т. Л. Каронова, А. О. Конради, Evgeny Vladimirovich ShlaykhtoDiagnostics 2023 · DOI

TL;DR

This study investigated myocardial damage in patients who died from COVID-19 across four distinct waves. While finding a decrease in myocarditis and endotheliitis complications over time, the direct link between SARS-CoV-2 infection and myocarditis remains unproven, suggesting potential activation of other viruses.

What Problem Does This Paper Address?

The COVID-19 pandemic has been associated with various cardiovascular complications, including myocarditis. However, understanding how the severity and nature of myocardial damage evolved across different waves of the pandemic, and crucially, establishing a definitive causal link between SARS-CoV-2 infection and myocarditis, has been challenging. Previous studies have yielded conflicting results regarding the presence of the virus in myocardial tissue and its role in causing inflammation. This paper aims to provide a comparative clinical and pathological analysis of myocardial damage in patients who succumbed to COVID-19 during four distinct waves, seeking to clarify these uncertainties.

Methods

The researchers conducted a comprehensive analysis of autopsy samples from 276 patients who died from COVID-19 across four waves. Their methodology involved:

  • Histological Examination: Standard hematoxylin and eosin staining of myocardium samples to assess general tissue structure and inflammation.
  • Immunohistochemistry (IHC): Using specific antibodies to identify various immune cells (CD3, CD45, CD8, CD68), endothelial markers (CD34, Ang1, VWF, VEGF), and viral antigens (enteroviral VP1, SARS-CoV-2 Spike protein). This was performed on a subset of samples.
  • Immunofluorescence (IF): To visualize and confirm the co-localization of enteroviral VP1 and SARS-CoV-2 Spike proteins in myocardial sections.
  • RT-ddPCR and RT-qPCR: Molecular techniques to detect SARS-CoV-2 RNA in myocardial tissue. RT-ddPCR was used for samples with confirmed myocarditis, while RT-qPCR was applied to samples from the fourth wave.
  • Electron Microscopy (EM): To examine the ultrastructure of myocardial vessels for the presence of viral particles.
  • Clinical Data Analysis: Review of patient histories, including comorbidities, laboratory results (e.g., C-reactive protein, D-dimer, troponin), CT scans, ECG, and echocardiography.

Datasets

The study utilized autopsy samples from 276 patients who died from COVID-19. These patients were categorized into four waves:

  • Wave I: 77 patients
  • Wave II: 119 patients
  • Wave III: 78 patients
  • Wave IV: 2 patients (due to limited availability and matching severity criteria)

Clinical and laboratory data were collected from these patients.

Key Insights and Ideas

  • Decreasing Myocarditis and Endotheliitis: A significant finding is the observed decrease in the incidence of myocarditis and endotheliitis-related complications (thrombosis, hemorrhage, necrosis) across the COVID-19 waves. This suggests a potential shift in the virus's impact or host response over time.
  • Unproven SARS-CoV-2 Causality: Despite investigating various markers, the study could not definitively prove that SARS-CoV-2 directly causes myocarditis. Viral RNA was not confidently detected in myocardial tissue of myocarditis cases, and SARS-CoV-2 Spike protein was only found in a small percentage of cells.
  • Enterovirus Activation Hypothesis: The high prevalence of enterovirus VP1 expression in myocarditis cases, particularly in vascular walls, suggests that SARS-CoV-2 might activate latent enteroviral infections, which could be the primary driver of myocardial damage in some instances.
  • Endothelial Damage as a Primary Target: The study strongly implicates endothelial dysfunction (endotheliitis) as a significant contributor to myocardial pathology, regardless of the presence of overt myocarditis. This aligns with findings of widespread vascular involvement in COVID-19.
  • Shift in Histological Features: While overall myocarditis decreased, the study noted an increase in "focal plasma soaking of the intima of the intramural arteries" in later waves, potentially indicating prolonged arterial spasm.

Key Results

  • Myocarditis Incidence: Active myocarditis was diagnosed in 5% (15/276) of the total cases.
  • Viral Antigen Presence: Enterovirus VP1 was expressed in 86% of myocarditis samples, while SARS-CoV-2 Spike protein was found in individual cells in 22% of these cases.
  • Viral RNA Detection: RT-ddPCR did not confidently detect SARS-CoV-2 RNA in the myocardium of myocarditis cases from waves I-III. A sub-threshold signal was detected in one case from wave IV, but myocarditis was not confirmed.
  • Endotheliitis: Immunohistochemistry confirmed endotheliitis in all 21 studied cases.
  • Histological Feature Trends:
    • Hemorrhage decreased from 48% (Wave I) to 24% (Wave II) and 17% (Wave III).
  • Myocardial necrosis decreased from 18% (Wave I) to 11% (Wave II) and 4% (Wave III).
  • Blood clots in intramural arteries decreased from 12% (Wave I) to 7% (Wave II) and 0% (Wave III).
  • Myocarditis incidence decreased from 19% (Wave I) to 1% (Wave II) and 6% (Wave III).
  • CD8+ T-killers: These immune cells were observed in later waves, suggesting a shift in the immune response.
  • Electron Microscopy: Single particles morphologically similar to SARS-CoV-2 virions were observed on the surface of endotheliocytes in one patient from wave IV.

Limitations and Future Work

  • Study Limitations:
    • The study did not account for patient treatment, which could influence outcomes.
  • Ultrastructural studies of the myocardium were not possible for patients from the first three waves.
  • The study did not specifically compare morphological changes during the Omicron wave.
  • The limited number of patients in wave IV restricted detailed analysis.
  • The study did not aim to compare ultrastructural changes across waves, only to demonstrate the possibility of viral particles.
  • Future Work:
    • The authors suggest that future research should focus on understanding the role of enteroviruses and their potential activation by SARS-CoV-2.
  • The potential for latent enterovirus infection in patients with cardiovascular diseases warrants further investigation.
  • The study highlights the need for further research into the connection between myocarditis and coronavirus infection, as it remains unproven.
  • The authors anticipate an increase in rhythm disturbances due to fibrosis formation after SARS-CoV-2 infection, especially in patients from the first wave, suggesting this as a future area of concern.

Summary updated

Abstract

This study compared myocardial damage in patients who died during three COVID-19 waves and showed a decrease in the incidence of endotheliitis complications (thrombosis, hemorrhage, necrosis) and myocarditis over time. However, the connection between myocarditis and SARS-CoV-2 infection remains unproven.
BibTeX
@inproceedings{2023comparative,
  author = {Л. Б. Митрофанова and Igor Makarov and Andrey Gorshkov and A. L. Runov and Maxim Vonsky and Maria Pisareva and Andrey B. Komissarov and T. А. Makarova and Qingli Li and Т. Л. Каронова and А. О. Конради and Evgeny Vladimirovich Shlaykhto},
  title = {{Comparative Study of the Myocardium of Patients from Four COVID-19 Waves}},
  booktitle = {Diagnostics},
  year = {2023},
  doi = {10.3390/diagnostics13091645},
}
Figure